Nurix Therapeutics Net Debt Growth & History (NRIX)

Nurix Therapeutics's net debt was −$191.2M for fiscal 2025.

View full Nurix Therapeutics company overview

Nurix Therapeutics annual net debt history

Nurix Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-11-30−$191.2M−$109.5M
20242024-11-30−$81.7M−$57.7M
20232023-11-30−$24.0M$28.5M
20222022-11-30−$52.5M$15.0M
20212021-11-30−$67.5M

Nurix Therapeutics net debt trends

Between the periods ended 2021-11-30 and 2025-11-30, Nurix Therapeutics's net debt decreased from −$67.5M to −$191.2M, a change of −$123.8M. The latest reported quarter, Q2 2026, shows −$9.5M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nurix Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about NRIX yet. Start the conversation.

Write the first post